These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38888319)

  • 1. Rapid
    Lawrence WS; Peel JE; Slayden RA; Peterson JW; Baze WB; Hensel ME; Whorton EB; Beasley DWC; Cummings JE; Macias-Perez I
    Antimicrob Agents Chemother; 2024 Jul; 68(7):e0011224. PubMed ID: 38888319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax.
    Heine HS; Bassett J; Miller L; Bassett A; Ivins BE; Lehoux D; Arhin FF; Parr TR; Moeck G
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3350-7. PubMed ID: 18606841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of dalbavancin against Bacillus anthracis in vitro and in a mouse inhalation anthrax model.
    Heine HS; Purcell BK; Bassett J; Miller L; Goldstein BP
    Antimicrob Agents Chemother; 2010 Mar; 54(3):991-6. PubMed ID: 20047912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Protective Immunity in New Zealand White Rabbits Challenged with Bacillus anthracis Spores and Treated with Antibiotics and Obiltoxaximab, a Monoclonal Antibody against Protective Antigen.
    Henning LN; Carpenter S; Stark GV; Serbina NV
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Bacillus anthracis Infection in BALB/c Mice and Cynomolgus Macaques.
    Grossman TH; Anderson MS; Drabek L; Gooldy M; Heine HS; Henning LN; Lin W; Newman JV; Nevarez R; Siefkas-Patterson K; Radcliff AK; Sutcliffe JA
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant protective antigen anthrax vaccine improves survival when administered as a postexposure prophylaxis countermeasure with antibiotic in the New Zealand white rabbit model of inhalation anthrax.
    Leffel EK; Bourdage JS; Williamson ED; Duchars M; Fuerst TR; Fusco PC
    Clin Vaccine Immunol; 2012 Aug; 19(8):1158-64. PubMed ID: 22695155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.
    Weiss S; Altboum Z; Glinert I; Schlomovitz J; Sittner A; Bar-David E; Kobiler D; Levy H
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7497-503. PubMed ID: 26392505
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Steenbergen J; Tanaka SK; Miller LL; Halasohoris SA; Hershfield JR
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosolized Bacillus anthracis infection in New Zealand white rabbits: natural history and intravenous levofloxacin treatment.
    Yee SB; Hatkin JM; Dyer DN; Orr SA; Pitt ML
    Comp Med; 2010 Dec; 60(6):461-8. PubMed ID: 21262133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teixobactin Provides Protection against Inhalation Anthrax in the Rabbit Model.
    Lawrence WS; Peel JE; Sivasubramani SK; Baze WB; Whorton EB; Beasley DWC; Comer JE; Hughes DE; Ling LL; Peterson JW
    Pathogens; 2020 Sep; 9(9):. PubMed ID: 32971758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax.
    Yamamoto BJ; Shadiack AM; Carpenter S; Sanford D; Henning LN; Gonzales N; O'Connor E; Casey LS; Serbina NV
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5796-805. PubMed ID: 27431219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with antibiotics and anthrax immune globulin intravenous (AIGIV) is potentially more effective than antibiotics alone in rabbit model of inhalational anthrax.
    Kammanadiminti S; Patnaikuni RK; Comer J; Meister G; Sinclair C; Kodihalli S
    PLoS One; 2014; 9(9):e106393. PubMed ID: 25226075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacillus anthracis protective antigen kinetics in inhalation spore-challenged untreated or levofloxacin/ raxibacumab-treated New Zealand white rabbits.
    Corey A; Migone TS; Bolmer S; Fiscella M; Ward C; Chen C; Meister G
    Toxins (Basel); 2013 Jan; 5(1):120-38. PubMed ID: 23344456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-exposure therapy of inhalational anthrax in the common marmoset.
    Nelson M; Stagg AJ; Stevens DJ; Brown MA; Pearce PC; Simpson AJ; Lever MS
    Int J Antimicrob Agents; 2011 Jul; 38(1):60-4. PubMed ID: 21530184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic considerations and efficacy of levofloxacin in an inhalational anthrax (postexposure) rhesus monkey model.
    Kao LM; Bush K; Barnewall R; Estep J; Thalacker FW; Olson PH; Drusano GL; Minton N; Chien S; Hemeryck A; Kelley MF
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3535-42. PubMed ID: 17065619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
    Gill SC; Rubino CM; Bassett J; Miller L; Ambrose PG; Bhavnani SM; Beaudry A; Li J; Stone KC; Critchley I; Janjic N; Heine HS
    Antimicrob Agents Chemother; 2010 May; 54(5):1678-83. PubMed ID: 20145081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of therapeutically administered gepotidacin in a rabbit model of inhalational anthrax.
    Hilliard JJ; Jakielaszek C; Mannino F; Hossain M; Qian L; Fishman C; Demons S; Hershfield J; Soffler C; Russo R; Henning L; Novak J; O'Dwyer K
    Antimicrob Agents Chemother; 2024 Mar; 68(3):e0149723. PubMed ID: 38358266
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of Combination Drug Therapy for Treatment of Antibiotic-Resistant Inhalation Anthrax in a Murine Model.
    Heine HS; Shadomy SV; Boyer AE; Chuvala L; Riggins R; Kesterson A; Myrick J; Craig J; Candela MG; Barr JR; Hendricks K; Bower WA; Walke H; Drusano GL
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696235
    [No Abstract]   [Full Text] [Related]  

  • 19. Effective antimicrobial regimens for use in humans for therapy of Bacillus anthracis infections and postexposure prophylaxis.
    Deziel MR; Heine H; Louie A; Kao M; Byrne WR; Basset J; Miller L; Bush K; Kelly M; Drusano GL
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5099-106. PubMed ID: 16304178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax.
    Peterson JW; Comer JE; Noffsinger DM; Wenglikowski A; Walberg KG; Chatuev BM; Chopra AK; Stanberry LR; Kang AS; Scholz WW; Sircar J
    Infect Immun; 2006 Feb; 74(2):1016-24. PubMed ID: 16428748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.